Supreme Court Backs Maker of Generic Heart Drug in 'Skinny Label' Case

The Supreme Court ruled that Amarin Pharma has not sufficiently proven that Hikma Pharmaceuticals' generic version of icosapent ethyl (Vascepa) infringes on its patents. The decision centers on a 'Skinny Label' case involving the heart drug.